Literature DB >> 15672416

Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.

Renee F Ren-Patterson1, Lauren W Cochran, Andrew Holmes, Suzanne Sherrill, Su-Jan Huang, Teresa Tolliver, Klaus-Peter Lesch, Bai Lu, Dennis L Murphy.   

Abstract

To study the neurochemical and behavioral effects of altered brain-derived neurotrophic factor (BDNF) expression on a brain serotonin system with diminished serotonin transport capability, a double-mutant mouse model was developed by interbreeding serotonin transporter (SERT) knockout mice with BDNF heterozygous knockout mice (BDNF +/-), producing SERT -/- x BDNF +/- (sb) mice. Prior evidence implicates serotonin and SERT in anxiety and stress responses. Some studies have shown that BDNF supports serotonergic neuronal development, leading to our hypothesis that reduced BDNF availability during development might exaggerate the consequences of absent SERT function. In the present study, brain serotonin and 5-hydroxyindol acetic acid concentrations in male sb mice were significantly reduced in the hippocampus and hypothalamus compared with wild-type control SB mice, BDNF-deficient Sb mice, and serotonin transporter knockout sB mice. The sb mice had significantly increased anxiety-like behaviors compared with SB, Sb, and sB mice as measured on the elevated plus maze test. These sb mice also had significantly greater increases in plasma adrenocorticotrophic hormone than mice with other genotypes after a stressful stimulus. Analysis of neuronal morphology showed that hypothalamic and hippocampal neurons exhibited 25-30% reductions in dendrites in sb mice compared with SB control mice. These findings support the hypothesis that genetic changes in BDNF expression interact with serotonin and other circuits that modulate anxiety and stress-related behaviors. Thus, this double-mutant mouse model should prove valuable in studying other gene x gene consequences for brain plasticity as well as in evaluating epistatic interactions of BDNF and serotonin transporter gene polymorphisms in neuropsychiatric disorders. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15672416     DOI: 10.1002/jnr.20410

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  30 in total

Review 1.  Refining psychiatric genetics: from 'mouse psychiatry' to understanding complex human disorders.

Authors:  Justin L Laporte; Renee F Ren-Patterson; Dennis L Murphy; Allan V Kalueff
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

2.  Interactive effect of 5-HTTLPR and BDNF polymorphisms on amygdala intrinsic functional connectivity and anxiety.

Authors:  Joshua Loewenstern; Xiaozhen You; Junaid Merchant; Evan M Gordon; Melanie Stollstorff; Joseph Devaney; Chandan J Vaidya
Journal:  Psychiatry Res Neuroimaging       Date:  2019-01-29       Impact factor: 2.376

3.  Interaction of COMT rs4680 and BDNF rs6265 polymorphisms on functional connectivity density of the left frontal eye field in healthy young adults.

Authors:  Wei Li; Bing Liu; Jiayuan Xu; Tianzi Jiang; Chunshui Yu
Journal:  Hum Brain Mapp       Date:  2016-03-23       Impact factor: 5.038

Review 4.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

Review 5.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

6.  Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.

Authors:  Abigail Polter; Sufen Yang; Anna A Zmijewska; Thomas van Groen; Ji-Hye Paik; Ronald A Depinho; Stanford L Peng; Richard S Jope; Xiaohua Li
Journal:  Biol Psychiatry       Date:  2008-09-27       Impact factor: 13.382

Review 7.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

Review 8.  Serotonin, genetic variability, behaviour, and psychiatric disorders--a review.

Authors:  Niklas Nordquist; Lars Oreland
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

9.  Study of the serotonin transporter (SLC6A4) and BDNF genes in French patients with non syndromic mental deficiency.

Authors:  Refaat Tabagh; Christian R Andres; Sylviane Védrine; Catherine Cherpi-Antar; Rose-Anne Thepault; Laurence Mignon; Diane Dufour-Rainfray; Claude Moraine; Patrick Vourc'h
Journal:  BMC Med Genet       Date:  2010-02-22       Impact factor: 2.103

Review 10.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.